Similar Articles
481 Extremely high titer of hepatitis B surface antigen antibodies in a primary hepatocellular carcinoma patient: A case report
482 Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
483 Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice
484 Trends of rapamycin in survival benefits of liver transplantation for hepatocellular carcinoma
485 Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatment
486 Immune aspects of hepatocellular carcinoma: From immune markers for early detection to immunotherapy
487 Characterization of metabolic landscape in hepatocellular carcinoma
488 Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
489 Deep learning applied to the imaging diagnosis of hepatocellular carcinoma
490 Application of artificial intelligence in preoperative imaging of hepatocellular carcinoma: Current status and future perspectives
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA